ETIHX
Price
$48.95
Change
+$0.36 (+0.74%)
Updated
Nov 19 closing price
Net Assets
1.58B
FSPHX
Price
$30.27
Change
+$0.15 (+0.50%)
Updated
Nov 19 closing price
Net Assets
6.22B
Interact to see
Advertisement

ETIHX vs FSPHX

Header iconETIHX vs FSPHX Comparison
Open Charts ETIHX vs FSPHXBanner chart's image
Eventide Healthcare & Life Sciences I
Price$48.95
Change+$0.36 (+0.74%)
VolumeN/A
Net Assets1.58B
Fidelity Select Health Care
Price$30.27
Change+$0.15 (+0.50%)
VolumeN/A
Net Assets6.22B
ETIHX vs FSPHX Comparison Chart in %
View a ticker or compare two or three
VS
ETIHX vs. FSPHX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETIHX is a Hold and FSPHX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSPHX has more cash in the bank: 6.22B vs. ETIHX (1.58B). FSPHX pays higher dividends than ETIHX: FSPHX (0.02) vs ETIHX (0.00). ETIHX was incepted earlier than FSPHX: ETIHX (13 years) vs FSPHX (44 years). ETIHX (1.32) is less costly to investors than FSPHX (0.63). ETIHX (41.00) and FSPHX (40.00) have comparable annual turnover. FSPHX has a lower initial minimum investment than ETIHX: FSPHX (0) vs ETIHX (100000). ETIHX annual gain was more profitable for investors over the last year : 42.08 vs. FSPHX (0.02). ETIHX return over 5 years is better than : -7.23 vs. FSPHX (-8.84).
ETIHXFSPHXETIHX / FSPHX
Total Expense Ratio1.320.63210%
Annual Report Gross Expense Ratio1.320.63210%
Fund Existence13 years44 years-
Gain YTD46.09110.532438%
Front LoadN/AN/A-
Min. Initial Investment1000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.58B6.22B25%
Annual Yield % from dividends0.000.02-
Returns for 1 year42.080.02248,907%
Returns for 3 years57.1010.47545%
Returns for 5 years-7.23-8.8482%
Returns for 10 years105.2039.34267%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CVTCX55.320.24
+0.44%
Calamos Growth & Income C
PEMGX42.33N/A
N/A
Principal MidCap A
BRUFX564.66N/A
N/A
Bruce
REMVX11.03N/A
N/A
RBC Emerging Markets Value Equity I
SPMHX8.48N/A
N/A
Invesco SteelPath MLP Alpha R5